Zotepine is a second‐generation antipsychotic that demonstrates significant efficacy in antagonizing D2 and 5‐HT2A receptors. Although clinical investigations have shown that administering zotepine is associated with an increased prevalence of hyperglycemia and a heightened risk of cardiovascular disease, the side effects of zotepine on voltage‐gated K+ (Kv) channels have not been established. Zotepine suppressed the vascular Kv channels in rabbit coronary arterial smooth muscle cells in a concentration‐dependent manner, with an IC50 of 5.3 ± 0.4 μM and a Hill coefficient of 1.6 ± 0.2. The decay rate of inactivation was significantly accelerated by zotepine. Applying zotepine (10 μM) shifted the steady‐state inactivation curve in a negative direction. Applying train pulses at 1 and 2 Hz resulted in a progressive increase in blockage of the Kv currents by zotepine. Furthermore, zotepine prolonged the recovery time from inactivation. Although pretreatment with the Kv2.1 subtype inhibitor stromatoxin‐1 and the Kv7 subtype inhibitor linopirdine did not change the degree of zotepine‐induced inhibition of Kv currents, pretreatment with the Kv1.5 channel inhibitor DPO‐1 decreased the inhibitory effects of zotepine on Kv currents. Zotepine also induced membrane depolarization. These results indicate that zotepine inhibits Kv currents (mainly Kv1.5 subtype) in dose‐, time‐, and use (state)‐dependent manners by changing the steady‐state inactivation curve.